Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of centrally acting drugs targeting neurological disorders. Its structural framework supports the creation of compounds with high selectivity for neurotransmitter receptors, making it valuable in the research and production of potential treatments for depression, anxiety, and other CNS-related conditions. The compound’s stereochemistry enables precise interactions in chiral environments, enhancing efficacy and reducing off-target effects in drug design.